The interleukins IL-6 and IL-1Ra: A mediating role in the associations between BMI and birth weight?

Journal of Developmental Origins of Health and Disease

Volumn 1, Issue 5, 2010, Pages 310-318

  Friis, C M ^a,b   Froslie K F ^b,c   Roislien J ^c   Voldner, N ^a   Godang, K ^b   Ueland, T ^b,d   Bollerslev, J ^b,e   Veierod M B ^c   Henriksen, T ^a,e  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

birth weight; BMI; inflammation; path analysis; pregnancy

Indexed keywords

EID: 84964862348     PISSN: 20401744     EISSN: 20401752     Source Type: Journal    
DOI: 10.1017/S204017441000036X     Document Type: Article

References (66)

1. Ehrenberg, HM, Mercer, BM, Catalano, PM. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol. 2004; 191, 964–968.
2. Mesman, I, Roseboom, TJ, Bonsel, GJ, et-al. Maternal pre-pregnancy body mass index explains infant's weight and BMI at 14 months: results from a multi-ethnic birth cohort study. Arch Dis Child. 2009; 94, 587–595.
3. Catalano, PM, Drago, NM, Amini, SB. Factors affecting fetal growth and body composition. Am J Obstet Gynecol. 1995; 172, 1459–1463.
4. Catalano, PM, Kirwan, JP. Maternal factors that determine neonatal size and body fat. Curr Diab Rep. 2001; 1, 71–77.
5. Jansson, N, Nilsfelt, A, Gellerstedt, M, et-al. Maternal hormones linking maternal body mass index and dietary intake to birth weight. Am J Clin Nutr. 2008; 87, 1743–1749.
6. Fleten, C, Stigum, H, Magnus, P, Nystad, W. Exercise during pregnancy, maternal prepregnancy body mass index, and birth weight. Obstet Gynecol. 2010; 115, 331–337.
7. Armitage, JA, Poston, L, Taylor, PD. Developmental origins of obesity and the metabolic syndrome: the role of maternal obesity. Front Horm Res. 2008; 36, 73–84.
8. King, JC. Maternal obesity, metabolism, and pregnancy outcomes. Annu Rev Nutr. 2006; 26, 271–291.
9. HAPO Study Cooperative Research Group. Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: associations with maternal body mass index. BJOG. 2010; 117, 575–584.
10. Sacks, DA, Liu, AI, Wolde-Tsadik, G, et-al. What proportion of birth weight is attributable to maternal glucose among infants of diabetic women? Am J Obstet Gynecol. 2006; 194, 501–507.
11. Owens, LA, O'Sullivan, EP, Kirwan, B, et-al. ATLANTIC DIP: the impact of obesity on pregnancy outcome in glucose tolerant women. Diabetes Care. 2010; 33, 577–579.
12. Jensen, DM, Damm, P, Sorensen, B, et-al. Pregnancy outcome and prepregnancy body mass index in 2459 glucose-tolerant Danish women. Am J Obstet Gynecol. 2003; 189, 239–244.
13. Cai, D, Yuan, M, Frantz, DF, et-al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med. 2005; 11, 183–190.
14. Meier, CA, Bobbioni, E, Gabay, C, et-al. IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin? J Clin Endocrinol Metab. 2002; 87, 1184–1188.
15. Bastard, JP, Maachi, M, Lagathu, C, et-al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006; 17, 4–12.
16. McIntyre, HD, Chang, AM, Callaway, LK, et-al. Hormonal and metabolic factors associated with variations in insulin sensitivity in human pregnancy. Diabetes Care. 2009.
17. Challier, JC, Basu, S, Bintein, T, et-al. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta. 2008; 29, 274–281.
18. Lash, GE, Ansari, T, Bischof, P, et-al. IFPA meeting 2008 workshops report. Placenta. 2009; 30(Suppl A), S4–S14.
19. Madan, JC, Davis, JM, Craig, WY, et-al. Maternal obesity and markers of inflammation in pregnancy. Cytokine. 2009; 47, 61–64.
20. Armitage, P, Colton, T. Encyclopedia of biostatistics. In Path Analysis (ed. Bollen KA), Vol. 4. 1998; pp. 3280–3284. John Wiley & Sons Ltd, West Sussex, England.
21. Voldner, N, Froslie, KF, Bo, K, et-al. Modifiable determinants of fetal macrosomia: role of lifestyle-related factors. Acta Obstet Gynecol Scand. 2008; 87, 423–429.
22. Sitras, V, Paulssen, R, Leirvik, J, Vartun, A, Acharya, G. Placental gene expression profile in intrauterine growth restriction due to placental insufficiency. Reprod Sci. 2009; 16, 701–711.
23. Ogge, G, Romero, R, Chaiworapongsa, T, et-al. Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia. J Matern Fetal Neonatal Med. 2009.
24. Wu, TL, Tsao, KC, Chang, CP, et-al. Development of ELISA on microplate for serum C-reactive protein and establishment of age-dependent normal reference range. Clin Chim Acta. 2002; 322, 163–168.
25. Shine, B, de Beer, FC, Pepys, MB. Solid phase radioimmunoassays for human C-reactive protein. Clin Chim Acta. 1981; 117, 13–23.
26. Belo, L, Santos-Silva, A, Rocha, S, et-al. Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. Eur J Obstet Gynecol Reprod Biol. 2005; 123, 46–51.
27. Hastie, T, Tibshirani, R, Friedman, J. The Elements of Statistical Learning. Data Mining, Inference, and Prediction, 2001. Springer Series in Statistics, Canada.
28. Ntzoufras, I. Bayesian Modeling Using WinBUGS, 2009. Wiley, New Jersey.
29. Sturtz, S, Ligges, U, Gelman, A. R2WinBUGS: a package for running WinBUGS from R. J Stat Softw. 2005; 12, 1–16.
30. Lunn, DJ, Thomas, A, Best, N, Spiegelhalter, D. WinBUGS – a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput. 2000; 10, 325–337.
31. Spiegelhalter, DJ, Best, NG, Carlin, BR, van der Linde, A. Bayesian measures of model complexity and fit. J R Stat Soc Series B-Stat Methodol. 2002; 64, 583–616.
32. Fields, SJ, Livshits, G, Sirotta, L, Merlob, P. Path analysis of risk factors leading to premature birth. Am J Hum Biol. 1996; 8, 433–443.
33. Sulkes, J, Fields, S, Gabbay, U, Hod, M, Merlob, P. Path analysis on the risk of mortality in very low birth weight infants. Eur J Epidemiol. 2000; 16, 337–341.
34. Gamborg, M, Andersen, PK, Baker, JL, et-al. Life course path analysis of birth weight, childhood growth, and adult systolic blood pressure. Am J Epidemiol. 2009; 169, 1167–1178.
35. Factor-Litvak, P, Sher, A. Invited commentary: coming out of the box. Am J Epidemiol. 2009; 169, 1179–1181.
36. Clausen, T, Burski, TK, Oyen, N, et-al. Maternal anthropometric and metabolic factors in the first half of pregnancy and risk of neonatal macrosomia in term pregnancies. A prospective study. Eur J Endocrinol. 2005; J, 887–894.
37. Ben-Haroush, A, Hadar, E, Chen, R, Hod, M, Yogev, Y. Maternal obesity is a major risk factor for large-for-gestational-infants in pregnancies complicated by gestational diabetes. Arch Gynecol Obstet. 2009; 279, 539–543.
38. Jensen, DM, Damm, P, Sorensen, B, et-al. Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus. Am J Obstet Gynecol. 2001; 185, 413–419.
39. Das, UN. Is obesity an inflammatory condition? Nutrition. 2001; 17, 953–966.
40. Ramsay, JE, Ferrell, WR, Crawford, L, et-al. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab. 2002; 87, 4231–4237.
41. Stewart, FM, Freeman, DJ, Ramsay, JE, et-al. Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab. 2007; 92, 969–975.
42. Retnakaran, R, Hanley, AJ, Raif, N, et-al. C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab. 2003; 88, 3507–3512.
43. Lee, DE, Kehlenbrink, S, Lee, H, Hawkins, M, Yudkin, JS. Getting the message across: mechanisms of physiological cross talk by adipose tissue. Am J Physiol – Endocrinol Metab. 2009; 296, E1210–E1229.
44. Fattori, E, Cappelletti, M, Costa, P, et-al. Defective inflammatory response in interleukin 6-deficient mice. J Exp Med. 1994; 180, 1243–1250.
45. Gabay, C, Kushner, I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999; 340, 448–454.
46. Feve, B, Bastard, JP. The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol. 2009; 5, 305–311.
47. Saltevo, J, Laakso, M, Jokelainen, J, et-al. Levels of adiponectin, C-reactive protein and interleukin-1 receptor antagonist are associated with insulin sensitivity: a population-based study. Diabetes Metab Res Rev. 2008; 24, 378–383.
48. Somm, E, Cettour-Rose, P, Asensio, C, et-al. Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents. Diabetologia. 2006; 49, 387–393.
49. Hauguel-de, MS, Guerre-Millo, M. The placenta cytokine network and inflammatory signals. Placenta. 2005.
50. Juge-Aubry, CE, Somm, E, Giusti, V, et-al. Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. Diabetes. 2003; 52, 1104–1110.
51. Aaltonen, R, Heikkinen, T, Hakala, K, Laine, K, Alanen, A. Transfer of proinflammatory cytokines across term placenta. Obstet Gynecol. 2005; 106, 802–807.
52. Catalano, PM, Presley, L, Minium, J, Hauguel-de, MS. Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care. 2009; 32, 1076–1080.
53. Nuamah, MA, Yura, S, Sagawa, N, et-al. Significant increase in maternal plasma leptin concentration in induced delivery: a possible contribution of pro-inflammatory cytokines to placental leptin secretion. Endocr J. 2004; 51, 177–187.
54. Dahlgren, J, Nilsson, C, Jennische, E, et-al. Prenatal cytokine exposure results in obesity and gender-specific programming. Am J Physiol Endocrinol Metab. 2001; 281, E326–E334.
55. Radaelli, T, Uvena-Celebrezze, J, Minium, J, et-al. Maternal interleukin-6: marker of fetal growth and adiposity. J Soc Gynecol Investig. 2006; 13, 53–57.
56. Juge-Aubry, CE, Somm, E, Chicheportiche, R, et-al. Regulatory effects of interleukin (IL)-1, interferon-beta, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue. J Clin Endocrinol Metab. 2004; 89, 2652–2658.
57. Wong, E, Freiberg, M, Tracy, R, Kuller, L. Epidemiology of cytokines: the Women On the Move through Activity and Nutrition (WOMAN) Study. Am J Epidemiol. 2008; 168, 443–453.
58. Yasui, T, Uemura, H, Yamada, M, et-al. Associations of interleukin-6 with interleukin-1beta, interleukin-8 and macrophage inflammatory protein-1beta in midlife women. Cytokine. 2008; 41, 302–306.
59. Schaefer-Graf, UM, Graf, K, Kulbacka, I, et-al. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care. 2008; 31, 1858–1863.
60. Sewell, MF, Huston-Presley, L, Amini, SB, Catalano, PM. Body mass index: a true indicator of body fat in obese gravidas. J Reprod Med. 2007; 52, 907–911.
61. Congdon, P. Applied Bayesian Modelling, 2003. Wiley, England.
62. Curry, AE, Vogel, I, Skogstrand, K, et-al. Maternal plasma cytokines in early- and mid-gestation of normal human pregnancy and their association with maternal factors. J Reprod Immunol. 2008; 77, 152–160.
63. Voldner, N. Modifiable determinants of newborn macrosomia and birth complications. Dissertation for the Degree of PhD 2010. Faculty of Medicine, University of Oslo.
64. Fewell, Z, Davey, SG, Sterne, JA. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study. Am J Epidemiol. 2007; 166, 646–655.
65. Delbaere, I, Vansteelandt, S, De Bacquer, D, et-al. Should we adjust for gestational age when analysing birth weights? The use of z-scores revisited. Hum Reprod. 2007; 22, 2080–2083.
66. Hernan, MA, Hernandez-Diaz, S, Werler, MM, Mitchell, AA. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol. 2002; 155, 176–184.